lifesciencesweden.se13h
New cell therapy raises hope for curing type 1 diabetes – "Never succeeded before"
For the first time, a patient with type 1 diabetes has undergone an islet transplantation using genetically modified ...
BioWorld1d
Sana soars on favorable type 1 diabetes phase I data
Shares of Sana Biotechnology Inc. (NASDAQ: SANA) were trading at $4.97, up $3.32, or 201%, on first results from an investigator-sponsored, first-in-human study transplanting UP-421, an allogeneic ...
Have mature skin? These award-winning beauty products make a difference
We reviewed hundreds of skin care and makeup products to bring you the best of Shop TODAY's 2024 Beauty Awards. From skin ...
Sana Biotechnology Stock Surges Over 200% On Wednesday - Here's Why
Sana Biotechnology's first-in-human study shows UP421 pancreatic islet cells surviving and functioning in type 1 diabetes ...
bovnews1d
Sana Biotechnology’s (SANA) Revolutionary Breakthrough Sends Stock Soaring
Sana Biotechnology’s innovative approach to treating type 1 diabetes centers around its HIP-modified pancreatic islet cell transplant. In the context of type 1 diabetes, the body’s immune system ...
Sana Biotechnology announces initial results from type 1 diabetes study
Sana Biotechnology (SANA) announced initial results from an investigator-sponsored, first-in-human study transplanting UP421, an allogeneic ...
Biomea Fusion Reports New Preclinical Data on Icovamenib-Semaglutide Combination Study
New in vivo preclinical data announced today, demonstrate that icovamenib, in combination with semaglutide showed additional 11.5% body weight reduction and 43% increase in lean muscle mass compared ...